Literature DB >> 17474106

Nogo-A marks motor neuron disease.

Noam Y Harel, Stephen M Strittmatter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17474106      PMCID： PMC2323439          DOI： 10.1002/ana.21145

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  12 in total

Review 1.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

2.  Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis.

Authors:  Anna Jurewicz; Mariola Matysiak; Cedric S Raine; Krzysztof Selmaj
Journal:  Neurology       Date:  2007-01-23       Impact factor: 9.910

3.  The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.

Authors:  Natasa Jokic; Jose-Luis Gonzalez de Aguilar; Leda Dimou; Shuo Lin; Anissa Fergani; Markus A Ruegg; Martin E Schwab; Luc Dupuis; Jean-Philippe Loeffler
Journal:  EMBO Rep       Date:  2006-10-13       Impact factor: 8.807

4.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.

Authors:  Y Yang; A Hentati; H X Deng; O Dabbagh; T Sasaki; M Hirano; W Y Hung; K Ouahchi; J Yan; A C Azim; N Cole; G Gascon; A Yagmour; M Ben-Hamida; M Pericak-Vance; F Hentati; T Siddique
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

Authors:  S Hadano; C K Hand; H Osuga; Y Yanagisawa; A Otomo; R S Devon; N Miyamoto; J Showguchi-Miyata; Y Okada; R Singaraja; D A Figlewicz; T Kwiatkowski; B A Hosler; T Sagie; J Skaug; J Nasir; R H Brown; S W Scherer; G A Rouleau; M R Hayden; J E Ikeda
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

6.  Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins.

Authors:  Pascal Steiner; Karina Kulangara; J C Floyd Sarria; Liliane Glauser; Romano Regazzi; Harald Hirling
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

7.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

Authors:  Agnes L Nishimura; Miguel Mitne-Neto; Helga C A Silva; Antônio Richieri-Costa; Susan Middleton; Duilio Cascio; Fernando Kok; João R M Oliveira; Tom Gillingwater; Jeanette Webb; Paul Skehel; Mayana Zatz
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

8.  A class of membrane proteins shaping the tubular endoplasmic reticulum.

Authors:  Gia K Voeltz; William A Prinz; Yoko Shibata; Julia M Rist; Tom A Rapoport
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

9.  Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.

Authors:  Luc Dupuis; Jose-Luis Gonzalez de Aguilar; Franck di Scala; Frédérique Rene; Marc de Tapia; Pierre-François Pradat; Lucette Lacomblez; Danielle Seihlan; Rabinder Prinjha; Frank S Walsh; Vincent Meininger; Jean-Philippe Loeffler
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

10.  Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.

Authors:  Markus Reindl; Sabrina Khantane; Rainer Ehling; Kathrin Schanda; Andreas Lutterotti; Claudia Brinkhoff; Thomas Oertle; Martin E Schwab; Florian Deisenhammer; Thomas Berger; Christine E Bandtlow
Journal:  J Neuroimmunol       Date:  2003-12       Impact factor: 3.478
View more
  1 in total

Review 1.  Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.

Authors:  Felicia Yu Hsuan Teng; Bor Luen Tang
Journal:  J Cell Mol Med       Date:  2008-04-15       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.